Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acipimox for Vascular Function in Type 2 Diabetes
NCT00153179Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Sep 2005
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acipimox in type 2 diabetes mellitus (T2DM), sponsored by Brigham and Women's Hospital. Started Sep 2005; status: completed.
02
Drugs
acipimox
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00153179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00153179.